“Autologous Hematopoietic Cell Transplantation For Hiv-Related Lymphoma: Results Of The Bmt Ctn 0803/amc 071 Trial.”. Blood 128 (8). Blood: 1050-8. doi:10.1182/blood-2015-08-664706.
. 2016. “Autologous Mesenchymal Stem Cells Produce Concordant Improvements In Regional Function, Tissue Perfusion, And Fibrotic Burden When Administered To Patients Undergoing Coronary Artery Bypass Grafting: The Prospective Randomized Study Of Mesenchymal Stem Ce”. Circ Res 114 (8). Circ Res: 1302-10. doi:10.1161/CIRCRESAHA.114.303180.
. 2014. “Blood And Marrow Transplant Clinical Trials Network Report On The Development Of Novel Endpoints And Selection Of Promising Approaches For Graft-Versus-Host Disease Prevention Trials.”. Biol Blood Marrow Transplant 24 (6). Biol Blood Marrow Transplant: 1274-1280. doi:10.1016/j.bbmt.2018.01.002.
. 2018. “Characteristics Of Clinimacs® System Cd34-Enriched T Cell-Depleted Grafts In A Multicenter Trial For Acute Myeloid Leukemia-Blood And Marrow Transplant Clinical Trials Network (Bmt Ctn) Protocol 0303.”. Biol Blood Marrow Transplant 18 (5). Biol Blood Marrow Transplant: 690-7. doi:10.1016/j.bbmt.2011.08.017.
. 2012. “Comparative Outcomes Of Donor Graft Cd34+ Selection And Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis For Patients With Acute Myeloid Leukemia In Complete Remission Undergoing Hla-Matched Sibling Allogeneic Hematopoietic Cell Transpl”. J Clin Oncol 30 (26). J Clin Oncol: 3194-201. doi:10.1200/JCO.2012.41.7071.
. 2012. “The Cord Blood Apgar: A Novel Scoring System To Optimize Selection Of Banked Cord Blood Grafts For Transplantation (Cme).”. Transfusion 52 (2). Transfusion: 272-83. doi:10.1111/j.1537-2995.2011.03278.x.
. 2012. “Intracoronary Cardiosphere-Derived Cells After Myocardial Infarction: Evidence Of Therapeutic Regeneration In The Final 1-Year Results Of The Caduceus Trial (Cardiosphere-Derived Autologous Stem Cells To Reverse Ventricular Dysfunction).”. J Am Coll Cardiol 63 (2). J Am Coll Cardiol: 110-22. doi:10.1016/j.jacc.2013.08.724.
. 2014. “Intracoronary Cardiosphere-Derived Cells For Heart Regeneration After Myocardial Infarction (Caduceus): A Prospective, Randomised Phase 1 Trial.”. Lancet 379 (9819). Lancet: 895-904. doi:10.1016/S0140-6736(12)60195-0.
. 2012. “Late Effects After Umbilical Cord Blood Transplantation In Very Young Children After Busulfan-Based, Myeloablative Conditioning.”. Biol Blood Marrow Transplant 22 (9). Biol Blood Marrow Transplant: 1627-1635. doi:10.1016/j.bbmt.2016.05.024.
. 2016. “Mismatched Related And Unrelated Donors For Allogeneic Hematopoietic Cell Transplantation For Adults With Hematologic Malignancies.”. Biol Blood Marrow Transplant 20 (10). Biol Blood Marrow Transplant: 1485-92. doi:10.1016/j.bbmt.2014.05.015.
. 2014. “Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant To Hypomethylating Therapy Or Best Supportive Care In Patients Aged 50 To 75 With Intermediate-2 And High-Risk Myelodysplastic Syndrome: Blood And M”. Biol Blood Marrow Transplant 20 (10). Biol Blood Marrow Transplant: 1566-72. doi:10.1016/j.bbmt.2014.06.010.
. 2014. “Myeloablative Transplantation Using Either Cord Blood Or Bone Marrow Leads To Immune Recovery, High Long-Term Donor Chimerism And Excellent Survival In Chronic Granulomatous Disease.”. Biol Blood Marrow Transplant 18 (9). Biol Blood Marrow Transplant: 1368-77. doi:10.1016/j.bbmt.2012.02.002.
. 2012. “A Novel Reduced-Intensity Conditioning Regimen For Unrelated Umbilical Cord Blood Transplantation In Children With Nonmalignant Diseases.”. Biol Blood Marrow Transplant 20 (3). Biol Blood Marrow Transplant: 326-36. doi:10.1016/j.bbmt.2013.11.021.
. 2014. “Optimizing Donor Selection For Public Cord Blood Banking: Influence Of Maternal, Infant, And Collection Characteristics On Cord Blood Unit Quality.”. Transfusion 54 (2). Transfusion: 340-52. doi:10.1111/trf.12257.
. 2014. “A Phase Ii/iii Randomized, Multicenter Trial Of Prednisone/sirolimus Prednisone/ Sirolimus/calcineurin Inhibitor For The Treatment Of Chronic Graft--Host Disease: Bmt Ctn 0801.”. Haematologica 103 (11). Haematologica: 1915-1924. doi:10.3324/haematol.2018.195123.
. 2018. “Randomized Comparison Of Allogeneic Versus Autologous Mesenchymal Stem Cells For Nonischemic Dilated Cardiomyopathy: Poseidon-Dcm Trial.”. J Am Coll Cardiol 69 (5). J Am Coll Cardiol: 526-537. doi:10.1016/j.jacc.2016.11.009.
. 2017. “Rationale And Design Of The Transendocardial Injection Of Autologous Human Cells (Bone Marrow Or Mesenchymal) In Chronic Ischemic Left Ventricular Dysfunction And Heart Failure Secondary To Myocardial Infarction (Tac-Hft) Trial: A Randomized, Double-Blind”. Am Heart J 161 (3). Am Heart J: 487-93. doi:10.1016/j.ahj.2010.11.024.
. 2011. “Recommendations For Donor Human Leukocyte Antigen Assessment And Matching For Allogeneic Stem Cell Transplantation: Consensus Opinion Of The Blood And Marrow Transplant Clinical Trials Network (Bmt Ctn).”. Biol Blood Marrow Transplant 21 (1). Biol Blood Marrow Transplant: 4-7. doi:10.1016/j.bbmt.2014.09.017.
. 2015. “Total Colony-Forming Units Are A Strong, Independent Predictor Of Neutrophil And Platelet Engraftment After Unrelated Umbilical Cord Blood Transplantation: A Single-Center Analysis Of 435 Cord Blood Transplants.”. Biol Blood Marrow Transplant 17 (9). Biol Blood Marrow Transplant: 1362-74. doi:10.1016/j.bbmt.2011.01.011.
. 2011. “Umbilical Cord Blood Transplantation In Children With Acute Leukemia: Impact Of Conditioning On Transplantation Outcomes.”. Biol Blood Marrow Transplant 23 (10). Biol Blood Marrow Transplant: 1714-1721. doi:10.1016/j.bbmt.2017.06.023.
. 2017.